Pharma Prospect Database
The Programmatic B2B Pharma Prospect Database is built from the Fortune 1000 list of top pharmaceutical companies, based on annual revenue. This database is available for email list rental, purchase or the comprehensive account-based marketing (ABM) program.
Every business contact email address must pass our triple email verification process. This process includes a 90 percent delivery score or greater from the email list owner, an independent third-party email address validation and a personalized B2B permission pass. Johnson & Johnson, Pfizer and Merck are among the 16 pharmaceutical companies represented here. The average annual revenue of a Fortune 1000 pharma company is about $25 billion USD.
| ABM Channel | Global Count | US Count | Price per 1,000 |
|---|---|---|---|
| Email Marketing | 202,912 | 109,139 | $210.00 |
| Display Advertising | 770,726 | 415,484 | $30.00 |
| Data License | 165,075 | 101,370 | $350.00 |
Customization & Intent Data
Unlike most pre-packaged data products, the Programmatic B2B Pharma Prospect Database allows you to construct custom audiences based on keyword combinations, intelligent title searches and all of the standard industry codes and job functions. Additional online intent signals may be applied as well, either by search retargeting or the aggregation of web history from our data partners.
| Company Name | US Rank | Employees | Revenue ($B) | Global Email | US Email | ||
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | 104 | 107,000 | 31.90 | 26,623 | 13,228 | ||
| AbbVie | 99 | 30,000 | 33.27 | 15,360 | 8,718 | ||
| Alexion Pharmaceuticals | 547 | 3,082 | 4.99 | 2,093 | 1,456 | ||
| Amgen | 135 | 23,400 | 23.36 | 13,129 | 9,992 | ||
| Biogen | 223 | 7,400 | 14.38 | 6,186 | 3,541 | ||
| Boston Scientific | 296 | 36,000 | 10.74 | 2,922 | 1,401 | ||
| Bristol-Myers Squibb | 115 | 30,000 | 26.15 | 13,376 | 8,551 | ||
| Eli Lilly | 145 | 33,625 | 22.32 | 9,937 | 5,552 | ||
| Gilead Sciences | 140 | 11,800 | 22.45 | 7,259 | 4,586 | ||
| Johnson & Johnson | 35 | 132,200 | 82.06 | 29,668 | 11,403 | ||
| Merck | 69 | 71,000 | 46.84 | 17,462 | 10,511 | ||
| Pfizer | 64 | 88,300 | 51.75 | 38,219 | 16,066 | ||
| Regeneron Pharmaceuticals | 405 | 8,100 | 7.86 | 5,608 | 4,392 | ||
| Vertex Pharmaceuticals | 626 | 3,000 | 4.16 | 2 | 700 | 2 | 068 |
| Zimmer Biomet Holdings | 399 | 19,900 | 7.98 | 8,290 | 5,156 | ||
| Zoetis | 472 | 10,600 | 6.26 | 4,080 | 2,518 |